Home > Specialists > Hematology > Dr. Jian Li (李剑)
Specialty & Clinical Focus:
Hematology specialist, Chief Physician and Department Director at Peking Union Medical College Hospital in Beijing, with a clinical focus on plasma cell disorders, POEMS syndrome, systemic light chain amyloidosis, Waldenström’s macroglobulinemia, Castleman disease, MGUS, and acute leukemia.
Professional Title & Qualifications:
-
Chief Physician,
-
Professor,
-
Doctoral Supervisor
Hospital & Department：
Peking Union Medical College Hospital (PUMCH) – Department of Hematology (Note: PUMCH is consistently ranked as the #1 hospital in China)
(address: No. 1 Shuaifuyuan, Dongdan, Dongcheng District, Beijing, 100730)
Dr. Jian Li (李剑) - Hematology Specialist & Researcher
Personal Biography
Dr. Jian Li is Director of the Department of Hematology, Chief Physician and Professor at Peking Union Medical College Hospital (PUMCH) in Beijing, with more than two decades of clinical experience. He earned his M.D. from Peking Union Medical College in 2001 and focuses on complex hematologic conditions, particularly plasma cell disorders, POEMS syndrome, systemic light chain amyloidosis and Waldenström’s macroglobulinemia.
His work in POEMS syndrome includes clinical cohort research and the development of prognostic stratification approaches. Dr. Li has authored more than 80 academic papers, including publications in Blood and Leukemia, with research spanning rare blood diseases, plasma cell disorders and related diagnostic and treatment pathways.
Why Choose Dr. Jian Li? (MedBridgeNZ Service Context)
Dr. Jian Li’s clinical and research background is particularly relevant for patients with complex plasma cell disorders, including POEMS syndrome, multiple myeloma, systemic light chain amyloidosis and Waldenström’s macroglobulinemia. As Director of Hematology at PUMCH, he combines long-term clinical experience with focused research in rare and difficult-to-classify blood diseases.
For international patients, a remote specialist review can be a practical first step before considering travel to Beijing. A well-prepared submission should include recent laboratory and pathology results, imaging where relevant, prior treatment records, current medications and a concise list of questions. This gives Dr. Li a clearer clinical timeline and helps the patient understand the specialist’s opinion, recommendations and possible next steps before making travel arrangements.
Pre-Travel Case Review & Specialist Liaison
Before arranging international travel for POEMS syndrome or another complex plasma cell disorder, MedBridgeNZ coordinates a structured remote specialist-review pathway with Dr. Jian Li at Peking Union Medical College Hospital. We organize the patient’s records, coordinate professional translation, securely transfer client-authorized documents and submit a focused question list for review.
Once the remote review is confirmed, Dr. Li reviews the submitted materials and provides an independent specialist opinion, recommendations and responses to the patient’s questions. MedBridgeNZ translates and relays the written response, coordinates follow-up communication and, if the patient decides to continue, assists with an in-person appointment request and practical travel planning for Beijing.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Jian Li
Areas of Expertise
Plasma Cell Disorders: Multiple Myeloma, Smoldering Myeloma
POEMS Syndrome: (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal protein, Skin changes) - Leader of the world's largest clinical cohort
Systemic Light Chain (AL) Amyloidosis: Early diagnosis and multidisciplinary management
Waldenström's Macroglobulinemia: (Lymphoplasmacytic Lymphoma)
Castleman Disease: Asian-specific clinical subtypes and treatment
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Acute Leukemia
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
6,600 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
2017 – Present: Chief Physician & Professor, Department of Hematology, Peking Union Medical College Hospital (PUMCH).
Current: Director, Department of Hematology, Peking Union Medical College Hospital.
2010 – 2017: Associate Chief Physician, Department of Hematology, PUMCH.
2005 – 2010: Attending Physician, Department of Hematology, PUMCH.
2001 – 2005: Resident Physician, PUMCH.
Education & Training
M.D., Peking Union Medical College, 2001.
Awards & Honors
Academic & Professional Memberships
Committee Member, Hematology Branch of the Chinese Medical Association.
Vice President, Hematologist Branch of the Beijing Medical Doctor Association.
Vice Chair, Rare Diseases Group, Hematology Branch of the Chinese Medical Association.
Committee Member, Multiple Myeloma Committee, Hematologist Branch of the Chinese Medical Doctor Association.
Editorial Board Member, Chinese Journal of Hematology.
Research & Publications
POEMS Syndrome Leadership: Established the largest single-center clinical cohort for POEMS syndrome globally.
Prognostic Innovation: Developed the first prognosis stratification system for POEMS syndrome.
Diagnostic Breakthroughs: Innovated multidisciplinary diagnostic techniques for Light Chain Amyloidosis using multi-omics imaging.
Castleman Disease: Defined clinical subtypes and treatment pathways specifically for Asian populations.
Project Leadership: Principal investigator for over 10 national and provincial-level research projects.
Selected Peer-Reviewed Publications
Ding Q, Li J, et al. Nerve ultrasound studies in POEMS syndrome. Muscle Nerve. 2021;63(5):758–764. PMID: 33604886
Zhang L, Dong YJ, et al. A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria. Lancet Reg Health West Pac. 2023;34:100720. PMID: 37283978
Wang X, Shen K, et al. Molecular Stratification of Light-Chain Cardiac Amyloidosis With 18F-Florbetapir and 68Ga-FAPI-04 for Enhanced Prognostic Precision. JACC Cardiovasc Imaging. 2025;18(3):323–336. PMID: 39797876
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
How can I determine whether Dr. Jian Li’s expertise is relevant to my condition?
Dr. Li’s clinical focus includes POEMS syndrome, multiple myeloma, systemic light chain amyloidosis, Waldenström’s macroglobulinemia, Castleman disease, MGUS and acute leukemia. International patients can begin with a structured remote specialist review. MedBridgeNZ organizes and translates the medical records, securely transfers the client-authorized documents and submits a focused question list. Once the review is confirmed, Dr. Li evaluates the submitted materials and provides his specialist opinion, recommendations and responses, helping the patient decide whether an in-person pathway in Beijing should be considered.
How can an international patient request an appointment with Dr. Li in Beijing?
For complex hematology cases, the recommended first step is to complete the remote review and clarify the purpose of an onsite visit. After the written response is received, MedBridgeNZ coordinates appointment-request communication with Peking Union Medical College Hospital, prepares the required administrative documents and assists with scheduling based on the hospital’s process and the specialist’s availability. We can also coordinate medical invitation or visa-document support, accommodation planning and transport arrangements if the patient decides to travel.
What language and administrative support is available during a hospital visit?
MedBridgeNZ can coordinate professional medical-record translation before the appointment and non-clinical bilingual administrative support during the hospital visit. This support can help the patient present translated documents, follow appointment procedures and communicate practical questions about registration, testing locations and the consultation process. Clinical explanations, diagnoses and treatment recommendations come from Dr. Li or the hospital team; our role is to support clear communication and manage the agreed logistical arrangements throughout the Beijing visit.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking specialist-review pathways with doctors such as Dr. Jian Li at PUMCH in Beijing. We assist with appointment-request coordination, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document support, travel planning and non-clinical bilingual administrative support. We do not provide medical advice, diagnosis or treatment. MedBridgeNZ coordination fees cover only the administrative services stated in the agreed scope; hospital, specialist and other third-party medical or travel charges remain separate unless expressly confirmed in writing.